
Successful Trial: 100 Days with a Titanium Heart
In a groundbreaking medical achievement, an Australian man in his mid-40s survived for 105 days with an artificial titanium heart while awaiting a donor transplant. This marks the longest duration a patient has lived with such a device before receiving a natural heart.
The device, known as the BiVACOR Total Artificial Heart, was implanted on November 22, 2024, at St. Vincent’s Hospital in Sydney. After spending a few weeks in the intensive care unit, the patient was discharged and lived at home for about a month before returning to the hospital for a successful donor heart transplant on March 6, 2025.
The BiVACOR heart, invented by Dr. Daniel Timms, utilizes magnetic levitation technology to replicate natural blood flow and is designed for patients with end-stage biventricular heart failure. This advancement offers hope for those awaiting transplants, potentially serving as a long-term solution or a bridge to donor organ availability.
This successful trial signifies a significant milestone in artificial heart technology, paving the way for future developments in cardiac care.
For a visual overview of this medical breakthrough, you can watch the following news report: